SKLB-1206

N/A

Report date: 2022/07/01 15:29:28

NME

Base Information

Drug NameSKLB-1206

Drug Alias NameSKLB-1206

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionReceptor protein-tyrosine kinase erbB-4 antagonistsVascular endothelial growth factor receptor 2 antagonistsEGFR T790M inhibitors +[4]

TargetsVascular endothelial growth factor receptor 2Receptor protein-tyrosine kinase erbB-2Receptor protein-tyrosine kinase erbB-4 +[4]

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSichuan University

China Registration ClassN/A

Develop Information

Active CompaniesSichuan University

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A